ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
Autore principale: | R.T. Saygitov |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
"Paediatrician" Publishers LLC
2008-08-01
|
Serie: | Вопросы современной педиатрии |
Accesso online: | https://vsp.spr-journal.ru/jour/article/view/1441 |
Documenti analoghi
Documenti analoghi
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
di: R.T. Saygitov
Pubblicazione: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
di: Cardile S, et al.
Pubblicazione: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
di: Yu. V. Yevsyutina
Pubblicazione: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
di: Gold Benjamin D, et al.
Pubblicazione: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
di: Roy C Orlando, et al.
Pubblicazione: (2010-09-01)